Recursion Pharmaceuticals (NasdaqGS:RXRX) reports its first AI enabled clinical proof of concept in familial adenomatous polyposis. The company advances five clinical programs, signaling broader use ...

If you are wondering whether Recursion Pharmaceuticals is a bargain or a value trap at its current share price, this article will walk you through how its valuation stacks up using several common ...

It's not looking too good for the biotech.

Elon Musk says Optimus 3 (teslabot) is essentially complete and will be by far the most advanced robot in the world. Nothing’s even close. The production ...

The AI industry is constantly churning out news, like major acquisitions, indie developer successes, public outcry, and ...

Hackers contacted employees at financial and healthcare organizations over Microsoft Teams to trick them into granting remote ...

The company racing to build the most powerful AI just created an institute to study the damage. That's not a contradiction Anthropic seems particularly embarrassed about. The San Francisco-based AI ...

Investment bank Morgan Stanley has warned that a major breakthrough in artificial intelligence (AI) could arrive in the first half of 2026. This could be driven by a rapid expansion of computing power ...

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

Hackers are impersonating IT staff in Microsoft Teams to trick employees into installing malware, giving attackers stealthy ...

In a hotel room in Santa Clara, Calif., five members of the AI company Anthropic huddled around a laptop, working urgently. It was February 2025, and they had been at a conference nearby when they ...

Anthropic launches the Anthropic Institute to study AI’s impact on jobs, governance, and security as the company warns rapid advances could reshape society.